Icon

CORLANOR (nda206143)- (EQ 5MG BASE,EQ 7.5MG BASE)

IVABRADINE HYDROCHLORIDE AMGEN INC
EQ 5MG BASE,EQ 7.5MG BASE
Yes No
2027-Jun-12 2020-Apr-15
None None
None No
Corlanor (ivabradine) is a hyperpolarization-activated cyclic nucleotide-gated channel blocker indicated: • To reduce the risk of hospitalization for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with reduced left ventricular ejection fraction. • For the treatment of stable symptomatic heart failure due to dilated cardiomyopathy in pediatric patients ages 6 months and older.
5 0 3
Total Other Developers 11
Drugs with Suitability No
EQ 5MG BASE ** ** Up - 3
EQ 7.5MG BASE ** ** Up - 3
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** ****** ****** ****** ******* ******* *********** ****** **. ***, ******* *******, *********** ******,, **********, ********* ******, ***** (***) ***
****** ***** ****** ***** ************ ******* *********** **** **. *-*/*&* *******, (******* ******** ****) ******, ******* ***** *.*. **. **, ***-******, ****-*********, *********, ******* ******, ***** (***) ***
****** ******* ****** *** ******* *************** ******* ******* *********** **** **. *, ************* ******* ****, *****-**, *********, ****, *********** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.